Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 413729, 4 pages
http://dx.doi.org/10.1155/2014/413729
Clinical Study

A Comparison of Intralesional Triamcinolone Acetonide Injection for Primary Chalazion in Children and Adults

Department of Ophthalmology, Caritas Medical Centre, 111 Wing Hong Street, Kowloon, Hong Kong Special Administrative Region, Hong Kong

Received 1 July 2014; Revised 1 July 2014; Accepted 18 September 2014; Published 15 October 2014

Academic Editor: Ahmad M. Mansour

Copyright © 2014 Jacky W. Y. Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose. To investigate outcome differences of intralesional triamcinolone acetonide (TA) injection for primary chalazia in children versus adults. Methods. A retrospective review of consecutive subjects with primary chalazion who received intralesional TA injection was conducted. A single investigator injected 0.05–0.15 mL of TA (40 mg/mL) intralesionally. Patients were stratified into the pediatric (<18 years old) and adult (≥18 years old) group. In both groups, the correlation of resolution time with chalazion size and TA dose was performed. Results. 17 children and 24 adults were enrolled, with a mean age of and years, respectively. Both groups had statistically similar baseline characteristics. There was no significant difference between the resolution time in the pediatric ( days) and adult ( days) group (). There were no significant complications from the TA injection. There was no significant correlation of resolution time to chalazion size () nor TA dose () in both groups. Conclusion. TA for the treatment of primary chalazion was equally effective in children and adults, without any significant complications, and the rate of clinical response did not appear to be dose-dependent.